Africa: DFC Announces Financing to Support Covid-19 Vaccine Manufacturing in South Africa

press release

Today, the U.S. International Development Finance Corporation (DFC) announced a joint financing package of €600 million for Aspen Pharmacare Holdings Ltd., headquartered in South Africa, to expand local vaccine manufacturing capacity. DFC is working together with DEG (Germany), Proparco (France), and the International Finance Corporation (IFC) to provide financing support. The package will help increase capacity to support Aspen's efforts to produce COVID-19 vaccines with Stringent Regulatory Authorization (SRA) and/or World Health Organization (WHO) Emergency Use Listing, including the Johnson & Johnson COVID-19 vaccine.

The vaccines will be primarily distributed to the African Union, South African Government, and COVAX.

This effort supports the Administration's goal to scale vaccine production, invest in African ingenuity and resilience, and help the global community beat this COVID-19 pandemic.

More From: State Department

Don't Miss

AllAfrica publishes around 800 reports a day from more than 130 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.

X